Acute myeloid leukemia in the elderly: A critical review of therapeutic approaches and appraisal of results of therapy

Leukemia and Lymphoma

Volumn 29, Issue 3-4, 1998, Pages 375-382

  Ferrara, Felicetto ^a,d   Mirto, Salvatore ^b   Zagonel, Vittorina ^c   Pinto, Antonio ^c  

^a CARDARELLI HOSPITAL   (Italy)

^b VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^d NONE   (Italy)

Author keywords

Acute myeloid leukemia; Elderly patients; Prognostic factors

Indexed keywords

HEMOPOIETIC GROWTH FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; HUMAN; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031846076     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809068573     Document Type: Article

References (24)

1. Brincker, H. (1985). Estimate of overall treatment results in acute nonlymphocytic leukemia based on age specific rates of incidence and of complete remission. Cancer Treat. Rep., 69, 5-11
2. Cartwright, R. A. and Staines, A. (1992). Acute leukemias. Epediomology of Haematological diseases. Part 1 (ed. by AT Fleming). Bailler's Clinical Hematology, 5, 1-26
3. Groupe Francaise de Morphologie Hematologique. (1987). French registry of acute leukemia and myelodysplastic sydrome: age distribution and hemogram analysis of the 4496 cases recorded during 1982-1983 and classified according to FAB criteria. Cancer, 60, 1385-1394
4. De Lima, M., Ghaddar, H., Pierce, S. and Estey, E. (1996). Treatment of newly diagnosed acute myelogenous leukaemia in patients aged 80 years and above. Brit. J. Haematol., 93, 89-95
5. Lowemberg, B. (1996). Treatment of the elderly patient with acute myeloid leukemia. Baillere's Clinical Haematology, 9, 157-159
6. Hamblin, T. H. (1995). Disappointments in treating acute leukemia in the elderly. New Engl. J. Med., 332, 1712-1713
7. Heinemann, V. and Jehn, U. (1991). Acute myeloid leukemia in the elderly:biological features and search for adequate treatment. Ann. Hematol., 63, 179-188
8. Johnson, P. R. E. (1993). Acute myeloid leukemia in the elderly: biology and treatment (Annotation). Brit. J. Haematol., 83, 1-6
9. Liu Yin, J. A., Johnson, P. R. E., Davies, J. M., Flanagan, N. G., Gorst, D. W. and Lewis, M. J. (1991). Mitozantrone and cytosine arabinoside in elderly patients with acute myeloid leukemia. Brit. J. Haematol., 79, 415-420
10. Ferrara, F., Mele, G., Mettivier, V., Mirto, R. and Cimino, R. (1992). Idarubicin in the treatment of acute myelogenous leukemia in the elderly. Leak. Lymphoma, 7 (suppl 2), 4-7
11. Heyll, A., Aul, C., Gogolin, F., Runde, V., Sohngen, D., Meckenstock, G., Wolf, H. H., Zahner, J., Burk, M., Winkelmann, M. and Schneider, W. (1994). Results of conventional-dose cytosine-arabinoside and idarubicin in elderly patients with acute myeloid leukemia. Ann. Hematol., 68, 279-283
12. Leoni, F., Ciolli, S., Giuliani, G., Pascarella, A., Caporale, R., Salti, F., Cervi, L. and Rossi Ferrini, P. L. (1995). Attenuated dose idarubicin in acute myeloid leukaemia of the elderly: pharmacokinetic study and clinical Results. Brit. J. Haematol., 90, 167-174.
13. Reiffers, J., Huguet, F., Stoppa, A. M., Molina, G., Marit, G., Attal, M., Gastaut, J. A., Michallet, M., Lepeu, G., Broustet, A., Pris, J., Maraninchi, D., Holland, D., Fabère, C., Mercier, M., Hurteloup, P., Danel, P., Tellier, Z. and Berthaud, P. (1996). A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75. Leukemia, 10, 389-395.
14. Baudard, M., Marie, J. P., Cadiou, M., Viguié, F. and Zittoun, R. (1994). Acute myelogenous leukemia in the elderly: retrospective study of 235 patients. Brit. J. Haematol, 86, 82-91.
15. Ruutu, T. and Elonen, E. (1991). Etoposide, 6-thioguanine and idarubicin, an oral combination regimen (ETI) for the induction treatment of acute leukemia. Hematol Oncol, 9, 87-92.
16. Johnson, P. R. E. and Liu Yin, A. L. (1994). Prognostic factors in elderly patients with acute myeloid leukaemia. Leuk. Lymphoma, 16, 51-56.
17. Ferrara, F. and Mirto, S. (1996). Serum LDH as a predictor of clinical outcome in acute myelogenous leukaemia of the elderly. Brit. J. Haematol, 92, 627-631
18. Bloomfield, C. D., Lawrence, D., Arthur, D. C., Berg, D. T., Schiffer, C. A. and Mayer, R. J. (1994). Curative impact of intensification with high-dose cytarabine (HiDAC) in acute myeloid leukemia (AML) varies by cytogenetic group. Blood, 84 (suppl 1), 111a.
19. Taylor, P. R. A., Reid, M. M., Stark, A. N., Bown, N., Hamilton, P. J. and Proctor, J. (1995). De Novo acute myeloid leukemia in patients over 55-years-old: a population-based study of incidence, treatment and outcome. Leukemia, 9, 231-237.
20. Leith, C. P., Kopecky, K. J., Chen, I-M., Godwin, J. E., Appelbaum, F. R., Head, D. R. and Willman, C. R. (1994). Correlation of functional efflux and multiple drug resistance (MDR1) expression in acute myeloid leukemia (AML) in the elderly: MDR1 and secondary AML status are independent predictors of complete remission (CR). Blood, 10 (suppl 1), 377a.
21. The Toronto Leukaemia Study Group. (1986). Results of chemotherapy for unselected patients with acute myeloblastic leukaemia: effect of exclusion on interpretation of results.Lancet, (i), 786-788.
22. Copplestone, J. A., Smith, A. G., Oscier, D. G. and Hamblin, T. J. (1986). True outlook in acute myeloblastic leukaemia. Lancet, (i, 1104.
23. Dombret, H., Chastang, C., Fenaux, P., Reiffers, J., Bordessoule, D., Bouabdallah, R., Mandelli, F., Ferrant, A., Auzanneau, G., Tilly, H., Yver, A. and Degos, L. (1995). A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. New Engl. J. Med., 332, 1678-1683
24. Stone, R. M., Berg, D. T., George, S. L., Dodge, R. K., Paciucci, P. A., Schulman, P., Lee, E. J., Moore, J. O., Powell, B. L. and Schiffer, C. A. (1995). Granulocyte-macrophage colony stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. New Engl. J. Med., 332, 1671-1677